Pharmaceutical Consultancy and FDA Advertising Regulations

In 2009, the US Food and Drug Administration (FDA) increased the number of warning letters sent to drug manufacturers about their advertising practices. The number of warnings issued was twice as high as in 2008.

The main complaint the FDA has in most of its warning letters is the misleading claims and overvaluing the benefits of some drugs that are untrue.

If you want to see the list who have received FDA warning letter, then you may browse

However, this warning can be avoided if the company has used pharmaceutical consultants to advise on their advertising strategy.

Image Source: Google

As you can see, it is not only the production process that can help pharmaceutical advice. There are strict regulations for the advertising, marketing and promotion of drugs. Therefore, manufacturers need to know what they can and cannot say about their products.

The over-effectiveness of the drug is a big prohibition if there is no evidence to support it. For example, photos and quotes from people who say that acne medication gives them completely clean and imperfect skin are overly excited because nothing from any research or research proves it.

Another example when promotional material could be classified as misleading is disease-specific drugs. Antiallergens targeting seasonal allergy treatments such as hay fever cannot be advertised as allergy relief from dust or for cleaning the house.

These types of manufacturer claims would have been avoided had pharmaceutical recommendations been used. In contrast, the company now faced reputational damage, lost profits, and an aura of suspicion in the future.